Alzheimer's Disease & Memory Disorders Center
The Largest Memory Assessment Program in Rhode Island
The Trailblazer-ALZ Study
If you would like to find out more or leave your information for the study team, please visit the Trailblazer trial information page, or call toll free, 1-844-562-6679 (1-844-5-MEMORY) or email email@example.com
Sponsored by Eli Lilly and Company, the purpose of Trailblazer-ALZ is to evaluate the safety, tolerability and efficacy of LY3002813 in early symptomatic Alzheimer's disease.
Intended for subjects with symptoms of memory impairment, the study drug in Trailblazer-ALZ is an experimental antibody treatment which targets beta amyloid proteins.
People who may be able to take part in this study:
- Are 60-85 years old
- Gradual and progressive change in memory function reported by patients or informants for ≥ 6 months
- Have a study partner who can go to some study visits to answer questions about the study participant’s symptoms
If you would like to find out more, please send your information to the study team online, and the coordinator will contact you. You can also call toll free at 1-844-563-6679, or email firstname.lastname@example.org.